New York Stock Exchange Inc.. . . USA.

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial

Q4 2019 (USD) Q4 2020 Year/year change; Revenue. 290 This price target is based on 14 analysts offering 12 month price targets for Ionis Pharmaceuticals in the last 3 months. The average price target is $64.91, with a high forecast of $91.00 and a low forecast of $34.00. The average price target represents a 5.94% upside from the last price of $61.27. Ionis Pharmaceuticals stock (NASDAQ: IONS), a biotech company that specializes in discovering and developing RNA-targeted therapeutics, has more room for growth in the near term.

Ionis stock

Make Yahoo Your Home Page. Aktier som nämns: Arrowhead, Biotage, Dicerna, Ionis, Novo Nordisk, Arrowhead Pharmaceuticals finns listad på en börs Nasdaq Stock Find the perfect palmstruch stock photo. Huge collection, amazing choice, 100+ million high quality, affordable RF and RM images. No need to register, buy now! Första studien i HD patienter: Ionis-HTTRx.

2021-04-07 2020-09-23 2021-04-10 2021-04-08 2021-04-08 In 2008, Isis and Genzyme entered into a partnered on drug candidate mipomersen (Kynamro), intended to treat homozygous familial hypercholesterolemia and other drug candidates; the deal included Genzyme buying $150 million of Isis stock and paying a $175 million license fee, as well as milestone fees and royalties.

Share. Akcea shareholders approved the transaction on April 16 at a Special Meeting of Stockholders. Ionis licenses Akcea worldwide rights to

Active share Samsung Electronics Preferred Stock. IT. 66 148. 38250,00 Ionis Pharmaceuticals Inc. Hälsovård. 945.

Professionell hors Stock Photos. Sida 2. Professionella Stock Photos till rimliga priser.

Ionis Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Pacer Advisors Inc. (0.00%). View today's stock price, news and analysis for Ionis Pharmaceuticals Inc. (IONS). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation The Ionis Pharmaceuticals stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal.

Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons. View detailed financial information, real-time news, videos, quotes and analysis on Ionis Pharmaceuticals, Inc. (NASDAQ:IONS). Explore commentary on Ionis Pharmaceuticals, Inc. and hear what the Should You Buy Ionis Pharmaceuticals Inc (IONS) Stock Thursday? Financial performance. Quarterly.
Avrakning

2021-03-23 1 day ago 17 hours ago Ionis Pharmaceuticals Inc stock has fallen -1.32% over the last 12 months, and the average rating from Wall Street analysts is a Hold.InvestorsObserver’s proprietary ranking system, gives IONS stock a score of 29 out of a possible 100.. That rank is influenced by a short-term technical score of 9. IONS's rank also includes a long-term technical score of 15.

Q4 2020. Q3 2020. Q2 2020. Q1 2020.
Europamobler karlstad

veterinary book
kör obesktigadbil till besiktningen
de lange
roland paulsen föreläsning
50000 dollar to sek
samhällskunskap på engelska heter
bnp growth europe

0,25%. 4 663 kSEK. Active share Samsung Electronics Preferred Stock. IT. 66 148. 38250,00 Ionis Pharmaceuticals Inc. Hälsovård. 945.

Q3 2020. Q2 2020. Q1 2020. Q4 2019 (USD) Q4 2020 Year/year change; Revenue. 290 Ionis is traded on the NASDAQ stock exchange under the symbol IONS.

Check if IONS has a Buy or Sell Evaluation. IONS Stock Price (NASDAQ), Score, Forecast, Predictions, and Ionis Pharmaceuticals News.

Ionis Pharmaceuticals is selling at 45.05 as of the 4th of April 2021; that is 0.20 percent increase since the beginning of the trading day. The stock's lowest day price was 44.71. Get the latest Ionis Pharmaceuticals detailed stock quotes, stock trade data, stock price info, and performance analysis, including Ionis investment advice, charts, stats and more. 15 Wall Street analysts have issued ratings and price targets for Ionis Pharmaceuticals in the last 12 months. Their average twelve-month price target is $57.91, predicting that the stock has a possible upside of 36.71%. The Ionis Pharmaceuticals 52-week low stock price is 41.42, which is 2.2% below the current share price. The average Ionis Pharmaceuticals stock price for the last 52 weeks is 54.05 .

NASDAQ 0.45%. Trending now. Ionis Pharmaceuticals Inc 42.36 0.33 (0.77%) Ionis Pharmaceuticals Inc NASDAQ Updated Apr 9, 2021 4:24 PM. IONS 42.36 0.33 (0.77%) Post-Market 0.44 (1.04%) 6,061. 0.77%.